Studying new drugs for HCV. Excerpts from the FDA hearing.
作者信息
Huff Bob
出版信息
GMHC Treat Issues. 2006 Aug-Dec;20(8-12):11-4.
PMID:17569164
Abstract
摘要
相似文献
1
Studying new drugs for HCV. Excerpts from the FDA hearing.研究丙型肝炎病毒的新药。美国食品药品监督管理局听证会摘录。
GMHC Treat Issues. 2006 Aug-Dec;20(8-12):11-4.
2
FDA notifications. FDA draft guidance on Hepatitis C/HIV coinfection.美国食品药品监督管理局通知。美国食品药品监督管理局关于丙型肝炎/艾滋病病毒合并感染的指导草案。
AIDS Alert. 2010 Nov;25(11):129-30.
3
Focus on hepatitis. Glimpses of hope on a distant horizon.
IAPAC Mon. 2004 Aug;10(8):300-1.
4
FDA approves Hep C drugs.
AIDS Alert. 2004 Jun;19(6):71.
5
FDA's meeting of Antiviral Drugs Advisory Committee.
AIDS Alert. 2006 Oct;21(10):118-9.
6
FDA notifications. Entecavir is approved for chronic hepatitis B infection in adults.
AIDS Alert. 2005 Jul;20(7):83-4.
7
8
FDA notifications. FDA approves generic foscarnet sodium injection.
AIDS Alert. 2005 Jul;20(7):82.
9
Testimony on accelerated approval.
GMHC Treat Issues. 2003 Nov;17(11):12.
10
New Indications for Harvoni.哈瓦尼的新适应症。
Med Lett Drugs Ther. 2016 Jan 4;58(1485):6.
Zotero 插件